
|Articles|May 1, 2003
Patients taking digoxin may develop color blindness
Author(s)J.G. Lawrenson, PhD, Nancy Groves
London-Routine testing for color vision deficiency is not a reliable method to detect digoxin toxicity in patients taking the drug for heart failure or other cardiac problems, said J.G. Lawrenson, PhD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Lotus submits NDA in South Korea for LENZ’s presbyopia treatment VIZZ
2
Belite Bio releases topline results from phase 3 DRAGON trial of Tinlarebant for STGD1
3
Collarettes common but largely stable in moderate-to-severe dry eye patients
4
EYDENZELT, Celltrion’s biosimilar referencing EYLEA, approved in Canada
5

















































.png)


